Hyperlipidemia plays a crucial role in the underlying pathogenesis of multiple
cardiovascular diseases (CVD), including coronary artery disease, peripheral arterial …

The increasing prevalence of type 2 diabetes is a major problem for healthcare providers
globally, since it is associated with serious microvascular and macrovascular complications …

Abstract Purpose of Review This article reviews current knowledge concerning diabetic
dyslipidemia and cardiovascular disease (CVD). It reviews strategies to reduce diabetes …

Dyslipidemias represent a variety of quantitative and/or qualitative lipoprotein abnormalities.
According to etiology, we distinguish primary dyslipidemias with strictly genetic background …

Coronary heart disease (CHD) is the leading cause of death in most countries, with the high
prevalence currently driven by dual epidemics of obesity and diabetes. Statin drugs, the …

Abstract Purpose of Review Dyslipidemia in patients with T2DM confers significant
additional risk of adverse outcomes to patients with cardiovascular disease (CVD). These …

Diabetes is associated with a high risk of cardiovascular disease. The management of
dyslipidemia, a well-recognized and modifiable risk factor among patients with type 2 …

Cardiovascular disease is a significant cause of morbidity and mortality in patients with
diabetes mellitus. The lipid profile of type 2 diabetes mellitus is characterized by increased …

Diabetic dyslipidemia is characterized by hepatic very low density lipoprotein (VLDL) and
intestinal chylomicron overproduction, reduced high density lipoprotein cholesterol (HDL-C) …

Background: Diabetic dyslipidemia has specifics that differ from dyslipidemia in patients
without diabetes, which contributes to accelerated atherosclerosis equally as dysglycemia …